Results 51 to 60 of about 212 (123)

The Relationship between Ischemic Stroke Patients with and without Retroflex Tongue: A Retrospective Study [PDF]

, 2017
Background. Patients suffering from stroke exhibit different levels of capability in retroflex tongues, in our clinical observation. This study aims to derive the association of tongue retroflexibility with the degree of severity for stroke patients ...
John Y. Chiang, Lun-Chien Lo, Mu-Chien Sun, Po-Chi Hsu, Yu-Liang Chen, Yung-Sheng Huang   +5 more
core   +2 more sources

CHInese medicine NeuroAiD efficacy on stroke recovery - Extension study (CHIMES-E): A multicenter study of long-term efficacy [PDF]

, 2015
© 2015 S. Karger AG, Basel. Background: The CHInese Medicine NeuroAiD Efficacy on Stroke recovery (CHIMES) study was an international randomized double-blind placebo-controlled trial of MLC601 (NeuroAiD) in subjects with cerebral infarction of ...
Alejandro C. Baroque II, Annabelle Y. Lao, Bernard P.L. Chan, Carlos L. Chua, Christopher L.H. Chen, Chun Fan Lee, Gaik Bee Eow, H. Asita de Silva, Herminigildo H. Gan, Hui Meng Chang, Joel M. Advincula, John Harold B. Hiyadan, Jose C. Navarro, K.S. Lawrence Wong, Narayanaswamy Venketasubramanian, Nijasri C. Suwanwela, Niphon Poungvarin, Nirmala Wijekoon, null null, San San Tay, Sherry H. Young, Sombat Muengtaweepongsa, Thirugnanam Umapathi   +22 more
core   +1 more source

Treatments for Post-Concussion Syndrome: A Systematic Review [PDF]

, 2022
Objective: To review current literature regarding interventions for post-concussive symptoms after experiencing mild traumatic brain injury (mTBI). Methods: Literature gathered through CINAHL and PubMed was assessed for the effectiveness of treatments ...
Conway, Sarah
core   +1 more source

Direct Stimulation of Adult Neural Stem/Progenitor Cells In Vitro and Neurogenesis In Vivo by Salvianolic Acid B [PDF]

, 2012
Background: Small molecules have been shown to modulate the neurogenesis processes. In search for new therapeutic drugs, the herbs used in traditional medicines for neurogenesis are promising candidates.
AA Davis, Adejobi Oluwaniyi Isaiah, B Wu, BA Reynolds, BA Reynolds, C Heurteaux, C Wang, CB Chan, DC Lie, DH Kim, E Bruel-Jungerman, F Yonemori, G Kwakkel, GH Du, GL Ming, Guangzhi Cui, H Kim, H Nakatomi, H Quintard, I Imayoshi, I Mook-Jung, J Liu, JE Le Belle, Jinbao Zhang, JJ Canales, Josef Priller, K Khodosevich, KP Doyle, L Zhou, M Jiang, M Tang, M Xu, MA Johnson, Mixia Zhang, MK Tang, N Shioda, NJ Kee, P Banta Lavenex, P Duncan, Pengwei Zhuang, R McKay, R Morris, RR Leker, S Jacobs, S Weiss, SJ Kim, T Chen, T Nitatori, T Takagi, T Yabe, VL Feigin, WA Pulsinelli, Xinpeng Yang, XY Ji, Y Yagita, Yang Liu, Yanjun Zhang, Yingxue Lin, Yongbo Jiang, YS Choi, Yuhong Bian   +60 more
core   +5 more sources

Microglial Activation and Neurological Symptoms in the SIV Model of NeuroAIDS: Association of MHC-II and MMP-9 Expression with Behavioral Deficits and Evoked Potential Changes

Neurobiology of Disease, 1999
HIV-1 causes cognitive and motor deficits and HIV encephalitis (HIVE) in a significant proportion of AIDS patients. Neurological impairment and HIVE are thought to result from release of cytokines and other harmful substances from infected, activated microglia.
Nancy E.J. Berman, Joanne K. Marcario, Chi Yong, Ravi Raghavan, Leigh A.M. Raymond, Sanjay V. Joag, Opendra Narayan, Paul D. Cheney   +7 more
openaire   +3 more sources

Microglial reactivity and nodule formation are associated with Synaptodendritic damage in the brains of people with HIV‐1

Brain Pathology, Volume 36, Issue 3, May 2026.
Despite effective ART, neurocognitive impairment persists in people with HIV. Brains from PWH present exacerbated microgliosis and formation of microglial nodules that are actively engaged in neuronal phagocytosis, resulting in neuronal injury and dendritic loss.
Roberta S. Dos Reis, Lauren A. Ignatz, Sathish Selvam, Marc C. E. Wagner, Sara Gianella, Antoine Chaillon, Vanessa Gomez‐Moreno, Jeremy Martison, Leah H. Rubin, Sabina Heberlen, Valentina Stosor, Jordan Lake, Velpandi Ayyavoo   +12 more
wiley   +1 more source

In Situ Gels for Nasal Delivery: Formulation, Characterization and Applications

Macromolecular Materials and Engineering, Volume 310, Issue 6, June 2025.
Drug delivery through the nasal route offers many advantages, but is hampered by a number of challenges, such as the short drug retention time caused by mucociliary clearance. In situ forming gels, which undergo a sol‐to‐gel transition with specific triggers at the site of action, present real opportunities in this field.
Li Qian, Michael T. Cook, Cécile A. Dreiss   +2 more
wiley   +1 more source

Interventions for visual field defects in people with stroke [PDF]

, 2019
BACKGROUND:Visual field defects are estimated to affect 20% to 57% of people who have had a stroke. Visual field defects can affect functional ability in activities of daily living (commonly affecting mobility, reading and driving), quality of life ...
Angilley, Jayne, Campbell, Pauline, Hazelton, Christine, Henderson, Clair A., Jonuscheit, Sven, Kernohan, Ashleigh, Langhorne, Peter, Pollock, Alex, Rowe, Fiona J.   +8 more
core   +5 more sources

Nanotechnology Approaches for Prevention and Treatment of Chemotherapy‐Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors

Small, Volume 20, Issue 41, October 10, 2024.
Advancements in nanomedicine have led to great potential for improving the fundamental flaws in chemotherapeutics for breast and ovarian cancer treatment. Many women who survive these impactful diseases have reduced quality of life due to off‐target effects from chemotherapy.
Sarah Nevins, Callan D. McLoughlin, Alfredo Oliveros, Joshua B. Stein, Mohammad Abdur Rashid, Yannan Hou, Mi‐Hyeon Jang, Ki‐Bum Lee   +7 more
wiley   +1 more source

Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options

European Journal of Neuroscience, Volume 59, Issue 6, Page 1359-1385, March 2024.
A brief overview of this review showing the formulation of a nanoparticle, a graphical representation of the BBB and the targeted effect of nanoparticles within the brain. Created using BioRender. Abstract Candidate drugs targeting the central nervous system (CNS) demonstrate extremely low clinical success rates, with more than 98% of potential ...
Ceinwyn G. Cooper, Konstantinos N. Kafetzis, Adjanie Patabendige, Aristides D. Tagalakis   +3 more
wiley   +1 more source